EE86 Healthcare Resource Utilization (HCRU) and Associated Costs Among Patients with Acute Myeloid Leukemia (AML) Treated with Oral Azacitidine as Maintenance and Those Eligible but Not Treated Using a US Claims Database

Abstract

Authors

U. Borate K. Seiter R. Potluri D. Mazumder W. Heydendael M. Chevli T. Prebet M. Strocchia A. Vasconcelos J. Sieluk